跳至主要内容
临床试验/ITMCTR2024000045
ITMCTR2024000045招募中未知

A multicenter controlled clinical trial on the improvement of sepsis-associated CCI muscular dystrophy by time-sharing administration(Day-3-Night-2) of Huanglian Decoction

Jiangsu Provincial Hospital of Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 85(—)
性别
All

入选标准

  • Inclusion Criteria
  • 1) Those who met the diagnostic criteria of sepsis-related CCI.
  • 2) Age between 18 and 85 years old, gender is not limited.
  • 3) Receive enteral nutrition therapy.
  • 4)No serious metabolic disease and other diseases of the digestive tract, such as radiation enteritis and broken bowel syndrome.
  • 5) Informed consent and volunteer to be tested.

排除标准

  • Exclusion Criteria
  • 1) ICU stay less than 14 days.
  • 2) Mechanical intestinal obstruction, gastrointestinal hemorrhage.
  • 3) Refusal or inability to perform enteral nutrition therapy.
  • 4) Frequent death or failure of resuscitation, inability to cooperate or refusal to complete the relevant examination.
  • 5) Pregnant and lactating women.
  • 6) Patients who are participating in clinical trials of other drugs.

研究者

发起方
Jiangsu Provincial Hospital of Chinese Medicine

相似试验